EEM vs IBB
iShares MSCI Emerging Markets ETF vs iShares Biotechnology ETF
- • IBB has the lower expense ratio at 0.44% vs 0.72% for EEM.
- • EEM pays a higher dividend yield (1.63%).
Side-by-side metrics
| Metric | EEM | IBB |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.72% | 0.44% |
Dividend yield Trailing 12-month yield. | 1.63% | 0.22% |
AUM Assets under management — bigger funds are typically more liquid. | $30.32B | $9.09B |
YTD return | 21.67% | 16.44% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.03 | 0.69 |
P/E ratio | 17.25 | 24.79 |
Last price | $66.92 | $196.62 |
Inception | — | — |
Issuer | iShares | iShares |
EEM top holdings
| 2330.TW | Taiwan Semiconductor Manufacturing Co Ltd | 15.05% |
| 005930.KS | Samsung Electronics Co Ltd | 8.14% |
| 000660.KS | SK Hynix Inc | 7.63% |
| 0700.HK | Tencent Holdings Ltd | 2.73% |
| 9988.HK | Alibaba Group Holding Ltd Ordinary Shares | 1.60% |
| 2454.TW | MediaTek Inc | 1.55% |
| 2308.TW | Delta Electronics Inc | 0.96% |
| 005935 | Samsung Electronics Co Ltd Participating Preferred | 0.89% |
| 402340.KS | SK Square | 0.82% |
| 2317.TW | Hon Hai Precision Industry Co Ltd | 0.78% |
IBB top holdings
| VRTX | Vertex Pharmaceuticals Inc | 8.07% |
| AMGN | Amgen Inc | 7.82% |
| GILD | Gilead Sciences Inc | 6.83% |
| REGN | Regeneron Pharmaceuticals Inc | 4.90% |
| ARGX | argenx SE ADR | 3.75% |
| ALNY | Alnylam Pharmaceuticals Inc | 3.12% |
| NTRA | Natera Inc | 2.89% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.78% |
| BIIB | Biogen Inc | 2.46% |
| ILMN | Illumina Inc | 2.07% |
About EEM
EEM (iShares MSCI Emerging Markets ETF) is Liquid emerging-market equities. Managed by iShares, the fund carries $30.3B in assets under management, an expense ratio of 0.72%, a dividend yield of 1.63%. Its largest holding is Taiwan Semiconductor Manufacturing Co Ltd (2330.TW), which represents 15.1% of the portfolio. Real Estate is the fund's largest sector exposure at 0.9%.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $9.1B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.22%. Its largest holding is Vertex Pharmaceuticals Inc (VRTX), which represents 8.1% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.